Healthcare products provider, Covidien (COV: Quote) announced that it has won a patent infringement suit against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, relating to Ethicon's Harmonic line of ultrasonic surgical products.
The company said that the federal court awarded it a $176.5 million verdict upon ruling that several claims of it's patents were valid, enforceable, and infringed by Ethicon. The amount of the verdict, which could be appealed, was based on an 8 percent royalty rate on infringing sales through March 2012, plus prejudgment interest.
The federal court found that Ethicon infringed Covidien's U.S. Patents 6,063,050, 6,468,286, and 6,682,544, each relating to ultrasonic cutting and coagulation surgical devices.
Click here to receive FREE breaking news email alerts for Covidien Ltd. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org